Transforming growth factor-beta receptors in human cancer cell lines: Analysis of transcript, protein and proliferation

Anticancer Research

Volumn 17, Issue 3 C, 1997, Pages 1849-1860

  Jakowlew, Sonia B ^a   Moody, Terry W ^a   Mariano, Jennifer M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Breast; Cancer; Ovary; Prostate; Receptor; TGF

Indexed keywords

MESSENGER RNA; OLIGONUCLEOTIDE; PROTEIN SERINE THREONINE KINASE; RESTRICTION ENDONUCLEASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; NORTHERN BLOTTING; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ACTIVIN RECEPTORS, TYPE I; BREAST NEOPLASMS; CELL DIVISION; DNA PRIMERS; FEMALE; HUMANS; KINETICS; MALE; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RESTRICTION MAPPING; RNA, MESSENGER; SEPHAROSE; TESTOSTERONE; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 0030810697     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Roberts AB, and Sporn MB: The transforming growth factor-β's. Poptide Growth Factors and Their Receptors. In: Sporn MB and Roberts AB (eds) Handbook of Experimental Pharmacology, Springer-Verrag, Germany, pp 414-772, 1990.
2. Massague' J, Cheifetz S, Laiho M, and Ralph DA: Transforming growth factor-beta. Cancer Surv 12: 81-103, 1992.
3. Chiefetz S, Weatherbee JA, Tsang MI-S, Andorsun JK, Mole JE, Lucas R, and Mussague' J: The transforming growth factor-beta system, a complex pattern of cross reactive ligands and receptors. Cell 48: 409-415, 1987.
4. Wu SP, Sun L-Z, Willson JKV, Humphrey L, Kerbel R, and Brattain MG: Repression of autocrine transforming growth factor β1 and β2 in quiescent CBS colon carcinoma cells leads to progression of tumorigenic properties. Cell Growth Diff 4: 115-123, 1993.
5. Kalkhoven E, Roelen BAJ, de Winter JP, Mummery CL, van den Eijnden-van Raaij AJM, van der Saag PT, and van der Burg B:Resistance to transforming growth factor β and activin due to reduced receptor expression in human breast tumor cell lines. Cell Growth Diff 6: 1151-1161, 1995.
6. Wakefield LM, Smith DM, Matsui T, Harris CC, and Sporn MB: Distribution and modulation of the cellular receptor for transforming growth factor-beta. J Cell Biol 105: 965-975, 1987.
7. Attisan L Wrana JL Lopez-Caillas F, and Massague' J: The transforming growth factor-β family. Ann Rev Cell Biol 6: 597-641, 1990.
8. Sun L Wu G, Willson JKV, Zborowska E, Yang J, Rajkarunanayake, Wang J,Gentry LE, Wang X-F, and Brattain MG: Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells. J Biol Chem 269: 26449-26455, 1994.
9. Wang J, Han W, Zborowska E, Liang J, Wang X-F, Willson JKV, Sun L and Brattain M: Reduced expression of transforming growth factor β type I receptor contributes to the malignancy of human colon carcinoma cells. J Biol Chem 271: 17366-17371, 1996.
10. Berns EMJJ, de Boer W, and Mulder E: Androgen dependent growth regulation and the release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate 9: 247-259, 1986.
11. Chirgwin JM, Przybyla AE, MacDonald RJ, and Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18: 5294-5299, 1979.
12. Aviv H, and Leder P: Purification of biologically active globin mRNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci USA 69: 1408-1412, 1972.
13. Church GM, and Gilbert W: Genomic sequencing. Proc Natl Acad Sci USA 80: 1991-1995, 1984.
14. Oian SW, Kondaiah P, Roberts AB, and Sporn MB: cDNA cloning by PCR of rat transforming growth factor-β1, Nuc Acids Res 18: 3059, 1990.
15. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, and Derynck R: Murine transforming growth factor-β2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 3: 1108- 1114, 1989.
16. Denhez F, Lafyatis R, Kondaiah P, Roberts AB, and Sporn MB: Cloning by polymerase chain reaction of a new mouse TGF-β, TGF- β3. Growth Factors 3: 1325-145, 1990.
17. Franzen P, ten Dijke P, Ichijo H, Yamashita H, Schulz P, Heldin C- H, and Miyazono K Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor. Cell 75: 681- 692, 1993.
18. Lin HY, Wang X-F, Ng-Eatpn E, Weinberg RA, and Lodish HF: Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase. Cell 68: 775-785, 1-992.
19. Sambrook J, Fritsch EF, and Manniatis. TE: In: Molecular cloning, a laboratory manual. 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989.
20. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-518, 1975.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254, 1976.
22. Winston SE, Fuller SA, and Hurrell JGR: Western blotting. In: Ausubel FM (ed) Current protocols in molecular biology, John Wiley and Sons, NY, pp 10.8.1-10.8.6, 1989.
23. Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin C- H, and Funa K Enhanced expression of transforming growth factor-β and its type I and type II receptors in human glioblastoma tissues. Int J Cancer 62: 386-392, 1995.
24. Mahmoud S, Staley J, Taylor J, Bogden A, Moreau JP, Coy D, Avis J, Cuttitta F, Mulshine J, and Moody TW (Psil3,14) Bombesin analogues inhibit the growth of small cell lung cancer in vitro and in vivo. Cancer Res 51: 1798-1802, 1991
25. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, and Sporn MB: Genetic changes in the transforming growth factors (TGF-β) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-β3. Proc Natl Acad Sci USA 91: 8772-8776, 1994.
26. Roberts AB, Anzano MA, Wakefield LM, Roche NS, Stern DF, and Sporn MB: Type β transforming growth factor: a bifunctional regulator of cellular growth. Proc Natl Acad Sci USA 82: 119-123, 1985.
27. Knabbe C, Lippman ME, Wakefield LM, Flanders KC Kasid A, Derynck R, and Dickson RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-428, 1987.
28. Arteaga CL, Tandon AK, Von Hoff DD, and Osborne CK: Transforming growth factor-β: Potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells. Cancer Res 48: 3898-3904, 1988.
29. Daly RJ, King RJB, and Darbe PD: Interaction of growth factors during progression towards steroid independence in T-47-D human breast cancer cells. J Cell Biol 43: 199-211, 1990.
30. Widing G, Zugmeier G, Knabbe C, Flanders K, and Gelmann E: Differential effects of transforming growth factor-β on human prostate cancer cells in vitro. Mol Cell Endocrinol 62: 79-87, 1989.
31. Zentella A, Weiss FM, Ralph DA, Laiho M, and Massague' J: Early gene responses to transforming growth factor-beta in cells lacking growth-suppressive RB function. Mol Cell Biol 11: 4952-4958, 1991.
32. Franzen P, Ichijo H, and Miyazono K: Different signals mediate transforming growth factor-β1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells. Exp Cell Res 207: 1-7, 1993.
33. Reddel RR, Alexander IE, Koga M, Shine J, and Sutherland RL: Genetic instability and the development of steroid hormone insensitivity in cultured T47D human breast cancer cells. Cancer Res 48: 4340-4347, 1988.
34. Graham ML, Dalguist KE, and Horwiiz KB: Simultaneous measurement of progesterone receptors and DNA indices by flow cytometry: analysis of breast cancer cell mixtures and genetic instability of the T47D line. Cancer Res 49: 3943-3949, 1989.
35. Schuurmans ALG, Bolt J, Veldscholte J, and Mulder E: Regulation of growth of LNCaP human prostate tumor cells by growth factors and steroid hormones. J Steroid Biochem Mol Biol 40: 193-197, 1991.
36. Carruba G, Leake RE, Rinaldi F, Chalmers D, Comito L, Sorci C, Pavone-Macaluso M, and Castagnetta LAM: Steroid-growth factor interaction in human prostate cancer. 1. Short-term effects of transforming growth factors on growth of human prostate cancer cells. Steroids 59: 412-420, 1994.
37. Kim IY, Ahn H-J, Zelner DJ, Shaw JW, Sensibar JA, Kim J-H, Kato M, and Lee C: Genetic changes in transforming growth factor β (TGF-β) receptor type I gene correlates with insensitivitv to TGFff1 in human prostate cancer cells. Cancer Res 56: 44-48, 1996a.
38. Sonnenschein C, Olea N, Pasanen ME, and Soto AM: Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res 49: 3474-3481, 1989.
39. Kim IY, Zelner DJ, Sensibar JA, Ahn H-J, Park L, Kim J-H, and Lee C: Modulation of sensitivity to transforming growth factors-β1 (TGF- β1) and the level of type II TGF-β receptor in LNCAP cells by dihydrotestosterone. Exp. Cell Res 222: 103-110, 1996b.
40. Jakowlew SB, Mathias A, Chung P, and Moody TW: Expression of transforming growth factor β ligand and receptor messenger RNAs in lung cancer cell lines. Cell Growth Diff 6: 465-476, 1995.
41. Norgaard P, Damstrup L, Rygaard K, Spang-Thomsen M, and Skovgaard Poulsen H: Growth suppression fey transforming growth factor-β1 of human small cell lung cancer cell lines is associated with expression of the type II receptor. Br J Cancer 69: 802-808, 1994.